|
|
|
|
|
|
Novo Nordisk A/S (NVO)
|
|
43.67 -0.04 (-0.09%)
|
6/22/2017 4:02pm
|
|
Open:
|
43.57
|
Pre. Close:
|
43.71
|
|
High:
|
43.92
|
Low:
|
43.49
|
|
Volume:
|
1,901,649
|
Market Cap:
|
108.99B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
43.92 - 44.33
|
44.33 - 44.61
|
|
Low:
|
42.8 - 43.29
|
43.29 - 43.63
|
|
Close:
|
43.22 - 43.78
|
43.78 - 44.17
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-22 4:40:36 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 51.81 One year: 60.52
|
|
Support:
|
Support1: 41.63 Support2: 39.95
|
|
Resistance:
|
Resistance1:
44.36 Resistance2: 51.81
|
|
Pivot:
|
43.25 
|
|
Moving Averages:
|
MA(5): 43.49 MA(20): 42.87
MA(100): 37.18 MA(250): 39.83 
|
|
MACD:
|
MACD(12,26):
0.92 Signal(12,26,9): 1.03
|
|
%K %D:
|
%K(14,3): 67.06 %D(3): 67.31
|
|
RSI:
|
RSI(14): 61.67
|
|
52-Week:
|
High: 57.41
Low: 30.89 Change(%): -14.2
|
|
Average Vol(K):
|
3-Month: 5891
10-Days 1870
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.NVO has closed below upper band by 29.2%. Bollinger Bands are 39.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Sat, 10 Jun 2017 09:56:15 GMT
Why Novo Nordisk A/S (ADR) Jumped 10.6% In May
Fri, 03 Jul 2009 09:03:16 GMT
43.71
Fri, 11 Feb 2011 10:09:45 GMT
Novo Nordisk A/S ADR NVO (US: NYSE)
Tue, 22 Nov 2016 16:55:25 GMT
Portfolio Update - Novo Nordisk Purchased
Fri, 03 Feb 2017 21:00:10 GMT
Novo Nordisk A/S Closes the Books on a Tough Year
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
